Single Variable Domain Formulation to Limit Stress-Induced Dimerization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing technologies face challenges in stabilizing and maintaining the monomeric form of single variable domains, leading to dimer formation that can affect binding functionality and stability, particularly under stress conditions such as high concentration and temperature.

Innovation Solution

Formulations containing excipients like polyols and non-reducing sugars, such as mannitol, sorbitol, and trehalose, are used to stabilize single variable domains, reducing dimer formation and maintaining binding activity under stress conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If single variable domains are stored under stress conditions (high concentration and temperature), then binding activity may be maintained, but dimer formation increases reducing stability

Engineering Contradiction:
Improvebinding activity retentionVSAvoidmonomeric form stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent introduces excipients (polyols, non-reducing sugars, amino acids) as intermediary substances that mediate between the single variable domains and the stress conditions. These excipients form protective complexes with the protein domains, preventing direct harmful interactions that lead to dimerization while allowing the domains to maintain their binding function under stress conditions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the physical and chemical parameters of the storage environment by adjusting excipient concentrations, pH levels, and ionic strength. These parameter changes create optimal conditions that favor monomeric stability while preserving binding activity, effectively resolving the contradiction between maintaining reliability under stress and preventing compositional instability.

Inventive Principle:
Principle #35Parameter changes

2Stability of the object's composition

If excipients are added to suppress dimer formation, then monomeric stability improves, but formulation complexity increases

Engineering Contradiction:
Improvemonomeric form stabilityVSAvoidformulation composition
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The patent applies local quality by selecting specific excipients with particular properties (polyols for hydrophilic protection, non-reducing sugars for structural stabilization, amino acids for charge interaction) and positioning them at optimal concentrations in the formulation. Each excipient class addresses specific local stability issues in the formulation, allowing complex functionality through targeted local improvements rather than uniform approaches.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The formulations achieve high stability and retention of binding activity, with less than 10% dimer formation and at least 80% activity retention after storage for up to two years under stress conditions, enhancing the stability and efficacy of single variable domain polypeptides.

Implementation Method 1

adding excipients that increase the melting temperature of the single variable domain such as for example by adding mannitol, other polyols or reducing sugars to a liquid formulation

Methodology Applied
Scientific EffectMelting temperature increase: Phase Change

Data Source

PatentUS12492239B2Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
Publication Date: 2025.12.09 ABLYNX NV
  • US12492239B2 patent drawing
  • US12492239B2 patent drawing
  • US12492239B2 patent drawing

AI summary

In a broad aspect the present invention generally relates to novel dimer-complexes (herein called “non-fused-dimers” or NFDs) comprising single variable domains, methods of making these complexes and uses thereof. These non-covalently bound dimer-complexes consist of two identical monomers that each comprises of one or more single variable domains (homodimers) or of two different monomers that each comprises on or more single variable domains (heterodimers). The subject NFDs have typically altered e.g. improved binding characteristics over their monomeric counterpart. The NFDs of the invention may further be engineered through linkage by a flexible peptide or cysteines in order to improve the stability. This invention also describes conditions under which such NFDs are formed and conditions under which the formation of such dimers can be avoided.